In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
After finishing at $238.86 in the prior trading day, West Pharmaceutical Services, Inc (NYSE: WST) closed at $237.28, down -0.66%. In other words, the price has decreased by -$0.66 from its previous closing price. On the day, 0.53 million shares were traded. WST stock price reached its highest trading level at $239.42 during the session, while it also had its lowest trading level at $233.67.
Ratios:
Our goal is to gain a better understanding of WST by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 33.47 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 49.60. For the most recent quarter (mrq), Quick Ratio is recorded 2.08 and its Current Ratio is at 2.78. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Barclays on June 24, 2025, initiated with a Equal Weight rating and assigned the stock a target price of $245.
On March 18, 2025, Evercore ISI started tracking the stock assigning a Outperform rating and target price of $275.
Deutsche Bank Upgraded its Hold to Buy on February 14, 2025, while the target price for the stock was maintained at $250.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 29 ’24 when Witherspoon Charles sold 703 shares for $310.40 per share. The transaction valued at 218,211 led to the insider holds 1,253 shares of the business.
Witherspoon Charles sold 1,029 shares of WST for $308,700 on Aug 19 ’24. The VP & Treasurer now owns 1,478 shares after completing the transaction at $300.00 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, WST now has a Market Capitalization of 17175773184 and an Enterprise Value of 16860669952. As of this moment, West’s Price-to-Earnings (P/E) ratio for their current fiscal year is 35.54, and their Forward P/E ratio for the next fiscal year is 31.48. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.52. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.76 while its Price-to-Book (P/B) ratio in mrq is 5.82. Its current Enterprise Value per Revenue stands at 5.696 whereas that against EBITDA is 21.356.
Stock Price History:
The Beta on a monthly basis for WST is 1.05, which has changed by -0.1902259 over the last 52 weeks, in comparison to a change of 0.19283521 over the same period for the S&P500. Over the past 52 weeks, WST has reached a high of $352.33, while it has fallen to a 52-week low of $187.43. The 50-Day Moving Average of the stock is 5.19%, while the 200-Day Moving Average is calculated to be -9.54%.
Shares Statistics:
The stock has traded on average 710.86K shares per day over the past 3-months and 1065200 shares per day over the last 10 days, according to various share statistics. A total of 71.90M shares are outstanding, with a floating share count of 71.45M. Insiders hold about 0.64% of the company’s shares, while institutions hold 97.28% stake in the company. Shares short for WST as of 1752537600 were 1831553 with a Short Ratio of 2.58, compared to 1749772800 on 2082235. Therefore, it implies a Short% of Shares Outstanding of 1831553 and a Short% of Float of 3.35.
Dividends & Splits
In the trailing 12 months, WST’s forward annual dividend rate was 0.83, compared to 0.84 this year. Against a Trailing Annual Dividend Yield of 0.0034748388The stock’s 5-year Average Dividend Yield is 0.24. The current Payout Ratio is 12.27% for WST, which recently paid a dividend on 2025-07-30 with an ex-dividend date of 2025-11-12. Stock splits for the company last occurred on 2013-09-27 when the company split stock in a 2:1 ratio.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 11.0 analysts currently analyzing and rating the stock of West Pharmaceutical Services, Inc (WST).The consensus estimate for the next quarter is $1.78, with high estimates of $1.83 and low estimates of $1.71.
Analysts are recommending an EPS of between $6.87 and $6.65 for the fiscal current year, implying an average EPS of $6.76. EPS for the following year is $7.55, with 13.0 analysts recommending between $7.89 and $7.34.
Revenue Estimates
10 analysts predict $788.41M in revenue for the current quarter. It ranges from a high estimate of $791.9M to a low estimate of $785M. As of the current estimate, West Pharmaceutical Services, Inc’s year-ago sales were $746.9MFor the next quarter, 10 analysts are estimating revenue of $796.36M. There is a high estimate of $804.6M for the next quarter, whereas the lowest estimate is $787.15M.
A total of 12 analysts have provided revenue estimates for WST’s current fiscal year. The highest revenue estimate was $3.06B, while the lowest revenue estimate was $3.04B, resulting in an average revenue estimate of $3.05B. In the same quarter a year ago, actual revenue was $2.89BBased on 12 analysts’ estimates, the company’s revenue will be $3.24B in the next fiscal year. The high estimate is $3.28B and the low estimate is $3.19B.
